Related Experiment Video
Updated: Dec 17, 2025
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Statin intensity and risk for cardiovascular events after heart transplantation
Jessica R Golbus1, Sarah Adie2, Matheos Yosef3
1Department of Medicine, Division of Cardiology, University of Michigan, Ann Arbor, MI, USA.
Insights
Higher intensity statin therapy after heart transplantation (HT) is linked to better cardiovascular outcomes. This study found greater statin intensity reduced primary events and vasculopathy, with no adverse events observed in high-intensity users.
Area of Science:
- Cardiology
- Transplantation Medicine
- Pharmacology
Background:
- Statins are known to improve survival and reduce complications like rejection and cardiac allograft vasculopathy post-heart transplantation (HT).
- The differential impact of varying statin intensities on clinical outcomes following HT has not been previously evaluated.
- Understanding statin intensity's role is crucial for optimizing post-transplant care.
Purpose of the Study:
- To determine the impact of different statin intensities on cardiovascular outcomes in patients who have undergone heart transplantation.
- To assess the association between statin intensity and key clinical events, including rejection and cardiac allograft vasculopathy.
Main Methods:
- A retrospective analysis of 346 adult patients undergoing HT between 2006 and 2018.
- Statin intensity was assessed longitudinally post-HT according to American College of Cardiology/American Heart Association guidelines.
- Primary outcome: time to first major adverse cardiovascular event. Secondary outcomes: time to significant rejection and cardiac allograft vasculopathy. Cox proportional hazards models were employed.
Main Results:
- Lower statin intensity was associated with a reduced time to primary adverse cardiovascular events (p ≤ 0.001).
- Greater statin intensity demonstrated the most benefit early after heart transplantation.
- No statin-related adverse events were reported in the 14 patients receiving high-intensity statin therapy.
Conclusions:
- Increased statin intensity is associated with a significant reduction in adverse cardiovascular outcomes after heart transplantation.
- Higher intensity statin use appears safe and beneficial in the early post-transplant period.
- These findings support the use of more intensive statin regimens to improve long-term outcomes in HT recipients.
Aims:
Statins improve survival and reduce rejection and cardiac allograft vasculopathy after heart transplantation (HT). The impact of different statin intensities on clinical outcomes has never been assessed. We set out to determine the impact of statin exposure on cardiovascular outcomes after HT.
Methods And Results:
We performed a retrospective study of 346 adult patients who underwent HT from 2006 to 2018. Statin intensity was determined longitudinally after HT based on American College of Cardiology/American Heart Association (ACC/AHA) guidelines. The primary outcome was the time to the first primary event defined as the composite of heart failure hospitalization, myocardial infarction, revascularization, and all-cause mortality. Secondary outcomes included time to significant rejection and time to moderate-severe cardiac allograft vasculopathy. Adverse events were evaluated for subjects on high-intensity statin therapy. A Cox proportional hazards model was used to evaluate the relationship between clinical variables, statin intensity, and outcomes. Most subjects were treated with low-intensity statin therapy although this declined from 89.9% of the population at 1month after HT to 42.8% at 5years after HT. History of ischaemic cardiomyopathy, significant acute rejection, older donor age, and lesser statin intensity (p ≤ 0.001) were associated with reduced time to the primary outcome in a multivariable Cox model. Greater intensity of statin therapy was most beneficial early after HT. There were no statin-related adverse events for the 14 subjects on high-intensity statin therapy.
Conclusions:
Greater statin intensity was associated with a reduction in adverse cardiovascular outcomes after HT.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
01:26Atherosclerosis III: Management
01:28Kidney Transplant I: Introduction
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
01:20Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...